Respiratory Disease News and Research RSS Feed - Respiratory Disease News and Research

Experts release position statement on electronic cigarettes

Experts release position statement on electronic cigarettes

Experts from the world's leading lung organizations have released a position statement on electronic cigarettes, focusing on their potential adverse effects on human health and calling on governments to ban or restrict their use until their health impacts are better known. [More]
WHO presents new framework to eliminate TB in 33 countries

WHO presents new framework to eliminate TB in 33 countries

The World Health Organization today, together with the European Respiratory Society, presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33 countries and territories where there are fewer than 100 TB cases per million population. [More]
Study finds deployment-related respiratory symptoms in veterans returning from Iraq, Afghanistan

Study finds deployment-related respiratory symptoms in veterans returning from Iraq, Afghanistan

In a new study of the causes underlying respiratory symptoms in military personnel returning from duty in Iraq and Afghanistan, a large percentage of veterans had non-specific symptoms that did not lead to a specific clinical diagnosis. [More]
Discovery may lead to new treatments for common autoimmune diseases

Discovery may lead to new treatments for common autoimmune diseases

Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system. [More]
‘Real-world’ ambrisentan data unveiled

‘Real-world’ ambrisentan data unveiled

The use of and outcomes with ambrisentan in clinical practice are different to those in clinical trials, reflecting different patient characteristics in the “real world”, say researchers. [More]
Study demonstrates link between obstructive sleep apnea and development of diabetes

Study demonstrates link between obstructive sleep apnea and development of diabetes

In the largest study to date of the relationship between sleep apnea and diabetes, a new study of more than 8,500 Canadian patients has demonstrated a link between obstructive sleep apnea (OSA) and the development of diabetes, confirming earlier evidence of such a relationship from smaller studies with shorter follow-up periods. [More]
Public health issues often ignored in many transportation projects

Public health issues often ignored in many transportation projects

A new study from the University of Colorado Denver shows public health issues are often ignored in many transportation projects, especially when major roads are built through lower-income neighborhoods. [More]
Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care, announce that the New Drug Application (NDA) for safinamide was submitted today to the US Food and Drug Administration (FDA). [More]
Ebola research: an interview with Professor Easton, University of Warwick

Ebola research: an interview with Professor Easton, University of Warwick

Ebola virus belongs to a group of viruses that have been known for some time. It was first isolated as a result of an infection in a primate, in a monkey colony, in monkeys that were being used for research in the Philippines. [More]
Pulmonary abnormalities may be precursor to chronic respiratory disease in Iraq/Afghanistan, Gulf War veterans

Pulmonary abnormalities may be precursor to chronic respiratory disease in Iraq/Afghanistan, Gulf War veterans

Pulmonary function abnormalities may be a precursor to chronic respiratory disease in Iraq/Afghanistan and Gulf War veterans years after their deployment, according to a new study presented at the 2014 American Thoracic Society International Conference. [More]
Legionnaires may be able to grow in windshield washer fluid

Legionnaires may be able to grow in windshield washer fluid

A form of bacteria responsible for respiratory illness, including the deadly pneumonia known as Legionnaire's disease, may be able to grow in windshield washer fluid and was isolated from nearly 75% of school buses tested in one district in Arizona, according to research presented today at the annual meeting of the American Society for Microbiology. [More]
Study shows commonly used statin drug does not reduce acute COPD exacerbations

Study shows commonly used statin drug does not reduce acute COPD exacerbations

A statin drug commonly used to lower cholesterol is not effective in reducing the number and severity of flare ups from chronic obstructive pulmonary disease (COPD), according to the results of a large multicenter clinical trial designed and directed by Gerard J. Criner, MD, Director of Pulmonary and Critical Care Medicine at Temple University Hospital in Philadelphia, PA. [More]
Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada announces top-line results from Phase II/III trial for treatment of inherited emphysema

Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of the Company's proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema). [More]
MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May. [More]
Tens of thousands of premature deaths could be prevented each year

Tens of thousands of premature deaths could be prevented each year

Heart disease, cancer, chronic lower respiratory diseases, stroke, and unintentional injuries cause nearly 900,000 premature deaths in the US each year. A recent study showed that 20–40% of deaths from each of these causes could be prevented. [More]
Researchers develop animal model of human hantavirus pulmonary syndrome

Researchers develop animal model of human hantavirus pulmonary syndrome

National Institutes of Health (NIH) researchers have developed an animal model of human hantavirus pulmonary syndrome (HPS) in rhesus macaques, an advance that may lead to treatments, vaccines and improved methods of diagnosing the disease. [More]
Scientists identify natural human antibodies against virus that causes MERS

Scientists identify natural human antibodies against virus that causes MERS

Scientists at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), a step toward developing treatments for the newly emerging and often-fatal disease. [More]
GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US. [More]
FDA proposes new regulations for tobacco products

FDA proposes new regulations for tobacco products

The American Thoracic Society applauds the Food and Drug Administration for moving forward with proposed rules to regulate all tobacco products, including e-cigarettes and cigars. This long awaited proposed rule is an important next step toward reducing the death and disease caused by tobacco use in the United States. [More]
Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria's origin and evolution. The new results could alter public health strategies to control this respiratory disease, which kills 195,000 children worldwide each year. [More]